Armetheon
Latest round
- Series B
Last raised
- Jan 2015
Total raised
- $31M
Investors
- 7
About Armetheon
Armetheon, Inc.Founded in 2011 and headquartered in Menlo Park, US, Armetheon, Inc. specializes in innovative medical treatments. In Q2 2017, the company merged with Espero Pharmaceuticals, Inc. to form Espero BioPharma, Inc.Armetheon, Inc. specializes in the development and commercialization of innovative therapeutic solutions, primarily focusing on advanced medical treatments. The company’s core product offerings include proprietary technologies designed to address unmet medical needs in various therapeutic areas. Their primary aim is to improve patient outcomes by providing solutions that enhance the efficacy and safety of treatments, which are intended for use in both hospital settings and outpatient care facilities.The revenue structure of Armetheon, Inc. is primarily driven by direct sales of its advanced therapeutic products and potential partnerships with healthcare providers and institutions. Transactions typically occur through B2B arrangements, where hospitals and clinics procure their products to enhance treatment options for patients.Armetheon, Inc. The company aims to introduce new therapeutic products, although specific launch dates are not disclosed. In addition, Armetheon is targeting expansions into new geographical markets to increase its reach. The merger with Espero Pharmaceuticals, Inc. in 2017 is expected to bolster its capabilities and product offerings. Through these initiatives, the company intends to strengthen its position within the healthcare market.
Who invested in Armetheon
7 investors across 2 rounds
See all investors in Armetheon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Armetheon
Who invested in Armetheon?
Armetheon has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Armetheon raised?
Armetheon has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Armetheon last raise money?
Armetheon's most recent round on record is a Series B, in Jan 2015.
What does Armetheon do?
Armetheon is a pharmaceuticals company.
Where is Armetheon headquartered?
Armetheon is headquartered in Menlo Park, US.
Which VCs invest in companies like Armetheon?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Armetheon's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Armetheon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.